Siemens Healthineers AG

SHL1

Company Profile

  • Business description

    Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.

  • Contact

    Siemensstrasse 3
    ForchheimBY91301
    DEU

    T: +49 9131843385

    https://www.siemens-healthineers.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 September 2026

    Employees

    74,000

Stocks News & Analysis

stocks

ASX healthcare giant rallies despite a fall in profits

Easing investor concerns and signalling a return to growth.
stocks

Weekly earnings wrap: BHP, CSL, NAB and more

Materials, banking, healthcare and retail heavyweights reveal diverging outlooks.
stocks

Chart of the Week: Our top dividend stock picks on the ASX

Highlighting key income opportunities on the ASX.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,295.7012.40-0.13%
CAC 408,501.917.45-0.09%
DAX 4026,091.3337.03-0.14%
Dow JONES (US)53,463.05119.650.22%
FTSE 10010,743.3515.310.14%
HKSE25,495.0723.920.09%
NASDAQ26,331.0941.380.16%
Nikkei 22566,168.93842.511.29%
NZX 50 Index13,937.988.310.06%
S&P 5007,707.9816.220.21%
S&P/ASX 2009,086.4015.40-0.17%
SSE Composite Index3,894.4295.88-2.40%

Market Movers